Literature DB >> 24231717

How is the increased risk of colorectal cancer in first-degree relatives of patients communicated?

Michael C Sulz1, Christa Meyenberger, Mikael Sawatzki.   

Abstract

OBJECTIVES: Compared with the general population, first-degree relatives (FDRs) of colorectal cancer (CRC) patients have a two-fold to four-fold higher risk of developing CRC. Little data is available regarding communication between doctors and CRC patients about risk to FDRs. We aimed to evaluate CRC patients' knowledge of FDRs' increased CRC risk, and FDRs' knowledge of this risk and adherence to CRC screening.
MATERIALS AND METHODS: In this retrospective, single-center, population-based observational study, patients aged 18-80 years who underwent surgery for CRC between January 2005 and May 2010 were asked to complete a questionnaire. A questionnaire sent to the patients' FDRs (siblings and children) asked whether they had been advised to undergo any CRC screening examination, whether they had done so, and if so, when initiated and by whom. Main outcome measurements were: CRC patients' and their FDRs' information status regarding the FDRs' increased CRC risk and screening status.
RESULTS: Of 343 index patients (390 contacted, 47 deceased/moved), 134 replied to the survey (39.1% response rate). Among index patients, 82.1% (110/134) were informed about FDRs' increased CRC risk. This information was provided mainly by gastroenterologists and general practitioners (65.7 and 28.4%, respectively). Among FDRs, 85.1% (143/168) were informed about their increased CRC risk, but 69% did not undergo a screening colonoscopy. Among the FDRs more than 50 years of age, 40.8% did not undergo a screening colonoscopy.
CONCLUSION: In Switzerland, CRC patients and their FDRs are well informed about FDRs' increased CRC risk. However, the majority of FDRs do not undergo the recommended CRC screening.

Entities:  

Mesh:

Year:  2014        PMID: 24231717     DOI: 10.1097/01.meg.0000437202.78275.4a

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.

Authors:  Alexander Bauer; Jürgen F Riemann; Thomas Seufferlein; Max Reinshagen; Stephan Hollerbach; Ulrike Haug; Susanne Unverzagt; Stephanie Boese; Madeleine Ritter-Herschbach; Patrick Jahn; Thomas Frese; Michael Harris; Margarete Landenberger
Journal:  Dtsch Arztebl Int       Date:  2018-10-26       Impact factor: 5.594

2.  Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.

Authors:  O Otero-Estévez; L De Chiara; F J Rodríguez-Berrocal; M Páez de la Cadena; J Cubiella; I Castro; C Gonzalez-Mao; V Hernandez; V S Martínez-Zorzano
Journal:  Br J Cancer       Date:  2014-12-02       Impact factor: 7.640

3.  Cancer risk awareness and screening uptake in individuals at higher risk for colon cancer: a cross-sectional study.

Authors:  Hamideh Salimzadeh; Faraz Bishehsari; Alireza Delavari; Gilda Barzin; Mohammad Amani; Azam Majidi; Alireza Sadjadi; Reza Malekzadeh
Journal:  BMJ Open       Date:  2016-12-20       Impact factor: 2.692

4.  Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.

Authors:  Olalla Otero-Estévez; Loretta De Chiara; Mar Rodríguez-Girondo; Francisco Javier Rodríguez-Berrocal; Joaquín Cubiella; Inés Castro; Vicent Hernández; Vicenta Soledad Martínez-Zorzano
Journal:  Sci Rep       Date:  2015-08-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.